GEODE CAPITAL MANAGEMENT, LLC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in LXRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,986,492
+$10,042,680 QoQ
Shares Held
6,244,372
+97.0% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. LXRX ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,986,492 | 6,244,372 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,943,812 | 3,169,111 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,875,024 | 2,500,022 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,237,195 | 2,397,923 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,258,808 | 2,377,694 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,697,064 | 3,689,271 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,605,728 | 3,521,255 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,532,633 | 3,523,971 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,460,898 | 3,250,535 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,733,928 | 2,389,137 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,593,841 | 2,348,916 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,317,489 | 2,126,137 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,214,600 | 1,840,437 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,192,743 | 1,725,409 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,071,167 | 1,607,941 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,765,652 | 1,569,022 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,495,028 | 1,341,413 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,628,935 | 1,257,864 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,719,091 | 1,197,739 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,742,764 | 1,193,922 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,878,201 | 1,280,654 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,328,787 | 1,078,158 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,631,990 | 769,588 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,115,938 | 774,957 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,637,750 | 818,875 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,338,288 | 686,302 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||